A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
In this work we provide an experimental workflow of how active enhancers can be identified and experimentally validated.
Embryonic development is a multistep process involving activation and repression of many genes. Enhancer elements in the genome are known to contribute to tissue and cell-type specific regulation of gene expression during the cellular differentiation. Thus, their identification and further investigation is important in order to understand how cell fate is determined. Integration of gene expression data (e.g., microarray or RNA-seq) and results of chromatin immunoprecipitation (ChIP)-based genome-wide studies (ChIP-seq) allows large-scale identification of these regulatory regions. However, functional validation of cell-type specific enhancers requires further in vitro and in vivo experimental procedures. Here we describe how active enhancers can be identified and validated experimentally. This protocol provides a step-by-step workflow that includes: 1) identification of regulatory regions by ChIP-seq data analysis, 2) cloning and experimental validation of putative regulatory potential of the identified genomic sequences in a reporter assay, and 3) determination of enhancer activity in vivo by measuring enhancer RNA transcript level. The presented protocol is detailed enough to help anyone to set up this workflow in the lab. Importantly, the protocol can be easily adapted to and used in any cellular model system.
Development of a multicellular organism requires precisely regulated expression of thousands of genes across developing tissues. Regulation of gene expression is accomplished in large part by enhancers. Enhancers are short non-coding DNA elements that can be bound with transcription factors (TFs) and act from a distance to activate transcription of a target gene1. Enhancers are generally cis-acting and most frequently found just upstream of the transcription start site (TSS), but recent studies also described examples where enhancers were found much further upstream, on the 3' of the gene or even within the introns and exons2.
1. Enhancer Selection Based on Chip-seq Analysis
We used a pan-specific RXR antibody in order to identify genome-wide which RA-regulated genes have receptor enrichment in their close proximity. Bioinformatics analysis of RXR ChIP-seq data obtained from ES cells treated with retinoic acid revealed the enrichment of the nuclear receptor half site (AGGTCA) under the RXR occupied sites (Figure 1). Using a bioinformatics algorithm we mapped back the motif search result for the half site to the RXR ChIP-seq data (Figu.......
In recent years, advances in sequencing technology have allowed large-scale predictions of enhancers in many cell types and tissues 7-9. The workflow described above allows one to perform primary characterization of candidate enhancers chosen based on ChIP-seq data. The detailed steps and notes will help anyone to set up a routine enhancer validation in the lab.
The most critical step in the luciferase reporter assay is the transfection efficiency. It is recommended to include a GFP.......
The authors have nothing to disclose.
The authors would like to acknowledge Dr. Bence Daniel, Matt Peloquin, Dr. Endre Barta, Dr. Balint L Balint and members of the Nagy laboratory for discussions and comments on the manuscript. L.N is supported by grants from the Hungarian Scientific Research Fund (OTKA K100196 and K111941) and co-financed by the European Social Fund and the European Regional Development Fund and Hungarian Brain Research Program - Grant No. KTIA_13_NAP-A-I/9.
....Name | Company | Catalog Number | Comments |
KOD DNA polymerase | Merck Millipore | 71085-3 | for PCR amplification of enhancer from gDNA |
DNeasy Blood & Tissue kit | Qiagen | 69504 | for genomic DNA isolation |
QIAquick PCR Purification kit | Qiagen | 28106 | for PCR product purification |
Gel extraction kit | Qiagen | 28706 | for gel extraction if there are more PCR product |
HindIII | NEB | R3104L | restriction enzyme |
BamHI | NEB | R3136L | restriction enzyme |
FastAP | Thermo Scientific | EF0651 | release of 5'- and 3'-phosphate groups from DNA |
T4 DNA ligase | NEB | M0202 | for ligation |
QIAprep Spin Miniprep kit | Qiagen | 27106 | for plasmid isolation |
DMEM | Gibco | 31966-021 | ES media |
FBS | Hyclone | SH30070.03 | ES media |
MEM Non-Essential Amino Acid | Sigma | M7145 | ES media |
Penicillin-Streptomycin | Sigma | P4333 | ES media |
Beta Mercaptoethanol | Sigma | M6250 | ES media |
FuGENE HD | Promega | E2311 | transfection reagent |
Opti-MEM® I Reduced Serum Medium | Life Technologies | 31985-062 | for transfection |
All-trans retinoic acid | Sigma | R2625 | ligand, for activation of RAR/RXR |
96-well clear plate | Greiner | 655101 | for Beta galactosidase assay |
96-well white plate | Greiner | 655075 | for Luciferase assay |
D-luciferin, potassium salt | Goldbio.com | 115144-35-9 | for Luciferase assay |
ATP salt | Sigma | A7699-1G | for Luciferase assay |
MgSO4x 7H2O | Sigma | 230391-25G | for Luciferase assay |
HEPES | Sigma | H3375-25G | for Luciferase assay |
Na2HPO4 x 7H2O | Sigma | 431478-50G | for Beta galactosidase assay |
NaH2PO4 x H2O | Sigma | S9638-25G | for Beta galactosidase assay |
MgSO4 x 7H2O | Sigma | 230391-25G | for Beta galactosidase assay |
KCl | Sigma | P9541-500G | for Beta galactosidase assay |
ONPG (o-nitrophenyl-β-D-galactosidase) | Sigma | N1127-1G | for Beta galactosidase assay |
TRIzol® | Life Technologies | 15596-026 | RNA isolation |
High-Capacity cDNA Reverse Transcription Kit | Life Technologies | 4368814 | reverse transcription of eRNA |
Rnase-free Dnase | Promega | M6101 | Dnase treatment |
SsoFast Eva Green | BioRad | 750000105 | RT-qPCR mastermix |
CFX384 Touch™ Real-Time PCR Detection System | BioRad | qPCR machine | |
BioTek Synergy 4 microplate reader | BioTek | luminescent counter |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved